Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes

Current Opinion in Infectious Diseases

Volumn 26, Issue 3, 2013, Pages 231-240

  Capoccia, Romina ^a   Greub, Gilbert ^b   Baud, David ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

chorioamnionitis; Mycoplasma; neonatal infections; prematurity; preterm premature rupture of fetal membranes; Ureaplasma

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; MACROLIDE;

ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CHORIOAMNIONITIS; HUMAN; MYCOPLASMA HOMINIS; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PREMATURE LABOR; REVIEW; UREAPLASMA UREALYTICUM;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREMATURE BIRTH; REPRODUCTIVE TRACT INFECTIONS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 84876879635     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328360db58     Document Type: Review

References (89)

1. Froen JF, Cacciatore J, McClure EM, et al. Stillbirths: why they matter. Lancet 2011; 377:1353-1366.
2. Soraisham AS, Singhal N, McMillan DD, et al. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009; 200:372.e1-372.e6.
3. Taylor-Robinson D, Lamont RF. Mycoplasmas in pregnancy. BJOG 2011; 118:164-174.
4. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757-789.
5. Dienes LaGE. Observations on the L-organism of Klieneberger. Proc Soc Exp Biol Med 1937; 36:740-744.
6. Shepard MC. The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonorrhea Vener Dis 1954; 38:113-124.
7. Larsen B, Hwang J. Mycoplasma, ureaplasma, and adverse pregnancy outcomes: a fresh look. Infect Dis Obstet Gynecol 2010; 2010:521921.
8. Taylor-Robinson D. The role of mycoplasmas in pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007; 21:425-438.
9. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24:498-514.
10. Bayraktar MR, Ozerol IH, Gucluer N, et al. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 2010; 14:e90-e95.
11. Choi SJ, Park SD, Jang IH, et al. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med 2012; 32:194-200.
12. Viscardi RM. Ureaplasma species: role in diseases of prematurity. Clin Perinatol 2010; 37:393-409.
13. Romero R, Oyarzun E, Mazor M, et al. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gynecol 1989; 73:576-582.
14. Carroll SG, Papaioannou S, Ntumazah IL, et al. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996; 103:54-59.
15. Clegg A, Passey M, Yoannes M, et al. High rates of genital mycoplasma infection in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J Clin Microbiol 1997; 35:197-200.
16. Breugelmans M, Vancutsem E, Naessens A, et al. Association of abnormal vaginal flora and Ureaplasma species as risk factors for preterm birth: a cohort study. Acta Obstet Gynecol Scand 2010; 89:256-260.
17. Harada K, Tanaka H, Komori S, et al. Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses. Microbiol Immunol 2008; 52:297-304.
18. Abele-Horn M, Scholz M, Wolff C, et al. High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery. Acta Obstet Gynecol Scand 2000; 79:973-978.
19. Abele-Horn M, Peters J, Genzel-Boroviczeny O, et al. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection 1997; 25:286-291.
20. Carey JC, Blackwelder WC, Nugent RP, et al. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1991; 164:728-733.
21. Horowitz S, Horowitz J, Mazor M, et al. Ureaplasma urealyticum cervical colonization as a marker for pregnancy complications. Int J Gynaecol Obstet 1995; 48:15-19.
22. Kafetzis DA, Skevaki CL, Skouteri V, et al. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality. Clin Infect Dis 2004; 39:1113-1122.
23. Lamont RF, Taylor-Robinson D, Wigglesworth JS, et al. The role of mycoplasmas, ureaplasmas and chlamydiae in the genital tract of women presenting in spontaneous early preterm labour. J Med Microbiol 1987; 24: 253-257.
24. Donders GG, Bosmans E, Dekeersmaecker A, et al. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 2000; 182:872- 878.
25. Kacerovský M, Pavlovsky M, Tosner J. Preterm premature rupture of the membranes and genital mycoplasmas. Acta Medica (Hradec Kralove) 2009; 52:117-120.
26. Rezeberga D, Lazdane G, Kroica J, et al. Placental histological inflammation and reproductive tract infections in a low risk pregnant population in Latvia. Acta Obstet Gynecol Scand 2008; 87:360-365.
27. Horowitz S, Mazor M, Horowitz J, et al. Antibodies to Ureaplasma urealyticum in women with intraamniotic infection and adverse pregnancy outcome. Acta Obstet Gynecol Scand 1995; 74:132-136.
28. Witt A, Berger A, Gruber CJ, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol 2005; 193:1663-1669.
29. Horowitz S, Mazor M, Romero R, et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995; 40:375-379.
30. Mitsunari M, Yoshida S, Deura I, et al. Cervical Ureaplasma urealyticum colonization might be associated with increased incidence of preterm delivery in pregnant women without prophlogistic microorganisms on routine examination. J Obstet Gynaecol Res 2005; 31:16-21.
31. Abele-Horn M, Wolff C, Dressel P, et al. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease. J Clin Microbiol 1997; 35:1199-1202.
32. Kataoka S, Yamada T, Chou K, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 2006; 44:51-55.
33. Govender S, Theron GB, Odendaal HJ, et al. Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy. J Obstet Gynaecol 2009; 29:698-701.
34. Gerber S, Vial Y, Hohlfeld P, et al. Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003; 187:518-521.
35. Marconi C, de Andrade Ramos BR, Peracoli JC, et al. Amniotic fluid interleukin- 1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor. Am J Reprod Immunol 2011; 65:549-556.
36. Namba F, Hasegawa T, Nakayama M, et al. Placental features of chorioamnionitis colonized with Ureaplasma species in preterm delivery. Pediatr Res 2010; 67:166-172.
37. Yoon BH, Romero R, Park JS, et al. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179:1254-1260.
38. Yoon BH, Chang JW, Romero R. Isolation of Ureaplasma urealyticumfrom the amniotic cavity and adverse outcome in preterm labor. Obstet Gynecol 1998; 92:77-82.
39. Ogasawara KK, Goodwin TM. The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum. Am J Perinatol 1997; 14:233-237.
40. Gauthier DW, Meyer WJ, Bieniarz A. Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone. Am J Obstet Gynecol 1994; 170:587-590.
41. Olomu IN, Hecht JL, Onderdonk AO, et al. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics 2009; 123:1329-1336.
42. Kirchner L, Helmer H, Heinze G, et al. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants. Eur J Obstet Gynecol Reprod Biol 2007; 134:44-50.
43. Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999; 8:12-16.
44. Kundsin RB, Leviton A, Allred EN, et al. Ureaplasma urealyticum infection of the placenta in pregnancies that ended prematurely. Obstet Gynecol 1996; 87:122-127.
45. McDonald HM, Chambers HM. Intrauterine infection and spontaneous midgestation abortion: is the spectrum of microorganisms similar to that in preterm labor? Infect Dis Obstet Gynecol 2000; 8:220-227.
46. Yoon BH, Romero R, Lim JH, et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003; 189:919-924.
47. Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183:1130-1137.
48. Jacobsson B, Aaltonen R, Rantakokko-Jalava K, et al. Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels. Acta Obstet Gynecol Scand 2009; 88:63-70.
49. Kacerovsky M, Pliskova L, Bolehovska R, et al. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol 2012; 206:342.e1-342.e8.
50. Kacerovsky M, Pliskova L, Bolehovska R, et al. The microbial load with genital mycoplasmas correlates with the degree of histologic chorioamnionitis in preterm PROM. Am J Obstet Gynecol 2011; 205:213.e1-213.e7.
51. Bujold E, Morency AM, Rallu F, et al. Bacteriology of amniotic fluid in women with suspected cervical insufficiency. JObstet Gynaecol Can 2008; 30:882- 887.
52. Grattard F, Soleihac B, De Barbeyrac B, et al. Epidemiologic and molecular investigations of genital mycoplasmas from women and neonates at delivery. Pediatr Infect Dis J 1995; 14:853-858.
53. Jacobsson B, Mattsby-Baltzer I, Andersch B, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 2003; 82:423-431.
54. Jacobsson B, Mattsby-Baltzer I, Andersch B, et al. Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet Gynecol Scand 2003; 82:120-128.
55. Lee SE, Romero R, Kim EC, et al. A high Nugent score but not a positive culture for genital mycoplasmas is a risk factor for spontaneous preterm birth. J Matern Fetal Neonat Med 2009; 22:212-217.
56. Nguyen DP, Gerber S, Hohlfeld P, et al. Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinatal Med 2004; 32: 323-326.
57. Goldenberg RL, Andrews WW, Goepfert AR, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008; 198:43.e1-43.e5.
58. Gonzalez Bosquet E, Gene A, Ferrer I, et al. Value of endocervical ureaplasma species colonization as a marker of preterm delivery. Gynecol Obstet Invest 2006; 61:119-123.
59. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009; 116:1315-1324.
60. Perni SC, Vardhana S, Korneeva I, et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004; 191:1382-1386.
61. Massaro G, Scaravilli G, Simeone S, et al. Interleukin-6 and Mycoplasma hominis as markers of preterm birth and related brain damage: our experience. J Matern Fetal Neonat Med 2009; 22:1063-1067.
62. Berg TG, Philpot KL, Welsh MS, et al. Ureaplasma/Mycoplasma-infected amniotic fluid: pregnancy outcome in treated and nontreated patients. J Perinatol 1999; 19:275-277.
63. Waites KB, Schelonka RL, Xiao L, et al. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonat Med 2009; 14:190-199.
64. Czikk MJ, McCarthy FP, Murphy KE. Chorioamnionitis: from pathogenesis to treatment. Clin Microbiol Infect 2011; 17:1304-1311.
65. Oh KJ, Lee KA, Sohn YK, et al. Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2010; 203: 211.e1-211.e8.
66. Waites KB, Xiao L, Paralanov V, et al. Molecular methods for the detection of mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14:437-450.
67. Xiao L, Glass JI, Paralanov V, et al. Detection and characterization of human ureaplasma species and serovars by real-time PCR. J Clin Microbiol 2010; 48:2715-2723.
68. Pascual A, Jaton K, Ninet B, et al. New diagnostic real-time PCR for specific detection of Mycoplasma hominis DNA. Int J Microbiol 2010; 2010:317512.
69. De Francesco MA, Caracciolo S, Bonfanti C, et al. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother 2012. [Epub ahead of print]
70. Gomez R, Romero R, Nien JK, et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonat Med 2007; 20:167-173.
71. Oh KJ, Lee SE, Jung H, et al. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. J Perinat Med 2010; 38:261-268.
72. Le Roy C, Le Hen I, ClercM, et al. The first performance report for the Bio-Rad Dx CT/NG/MG assay for simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in urogenital samples. J Microbiol Methods 2012; 89:193-197.
73. Muvunyi CM, Dhont N, Verhelst R, et al. Evaluation of a new multiplex polymerase chain reaction assay STDFinder for the simultaneous detection of 7 sexually transmitted disease pathogens. Diagn Microbiol Infect Dis 2011; 71:29-37.
74. Schnee C, Schulsse S, Hotzel H, et al. A novel rapid DNA microarray assay enables identification of 37 Mycoplasma species and highlights multiple Mycoplasma infections. PloS One 2012; 7:e33237.
75. Smorgick N, Frenkel E, Zaidenstein R, et al. Antibiotic treatment of intraamniotic infection with Ureaplasma urealyticum. A case report and literature review. Fetal Diagn Ther 2007; 22:90-93.
76. Murray PR, Rosenthal KS, Pfaller MA. Mycoplasma. In: Medical microbiology. 9th ed. Washington: Saunders; 2013.
77. Ramsey PS, Vaules MB, Vasdev GM, et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188:714- 718.
78. Heikkinen T, Laine K, Neuvonen PJ, et al. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107:770-775.
79. Guven MA,Gunyeli I, Dogan M, et al. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. Arch Gynecol Obstet 2005; 272:197-200.
80. Grigsby PL, Novy MJ, Sadowsky DW, et al. Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate model. Am J Obstet Gynecol 2012; 207:475.e1- 475.e14.
81. Romero R, Hagay Z, Nores J, et al. Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. Am J Obstet Gynecol 1992; 166:618-620.
82. Eschenbach DA, Nugent RP, Rao AV, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1991; 164:734-742.
83. Mazor M, Chaim W, Horowitz S, et al. Successful treatment of preterm labour by eradication of Ureaplasma urealyticum with erythromycin. Arch Gynecol Obstet 1993; 253:215-218.
84. Baud D, Thomas V, Arafa A, et al. Waddlia chondrophila, a potential agent of human fetal death. Emerg Infect Dis 2007; 13:1239-1243.
85. Baud D, Regan L, Greub G. Emerging role of Chlamydia and Chlamydia-like organisms in adverse pregnancy outcomes. Curr Opin Infect Dis 2008; 21:70-76.
86. Baud D, Greub G. Intracellular bacteria and adverse pregnancy outcomes. Clin Microbiol Infect 2011; 17:1312-1322.
87. Baud D, Goy G, Osterheld MC, et al. Waddlia chondrophila: from bovine abortion to human miscarriage. Clin Infect Dis 2011; 52:1469-1471.
88. Goy G, Greub G. Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae. Antimicrob Agents Chemother 2009; 53:2663-2666.
89. McCormackWM,Rosner B, Lee YH, et al. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol 1987; 69:202-207.